Cerenome (PSTV) EBITDA Margin Growth (5y) (2016 - 2024)
Cerenome (PSTV) EBITDA Margin Growth (5y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 11,139.00 |
| Dec 31, 2023 | -15,951.00 |
| Sep 30, 2023 | -262.00 |
| Jun 30, 2023 | 20,128.00 |
| Mar 31, 2023 | -34,905.00 |
| Dec 31, 2022 | -383,906.00 |
| Sep 30, 2022 | -604,810.00 |
| Mar 31, 2019 | 61,789.00 |
| Dec 31, 2018 | 20,260.00 |
| Sep 30, 2018 | 26,402.00 |
| Jun 30, 2018 | 17,222.00 |
| Mar 31, 2018 | -11,137.00 |
| Dec 31, 2017 | -47,874.00 |
| Sep 30, 2017 | -14,368.00 |
| Jun 30, 2017 | -21,848.00 |
| Mar 31, 2017 | -64,144.00 |
| Dec 31, 2016 | 4,283.00 |
| Sep 30, 2016 | -28,964.00 |
| Jun 30, 2016 | -37,142.00 |
| Mar 31, 2016 | 44,311.00 |